Profile

Antiverse

Antiverse is building a world-first computational antibody drug discovery platform. They combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in one day.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website www.antiverse.io/

Associated Team Members

Blog

Is Your Business Plan Hitting The Mark For Investors?

Midven explores how SMEs effectively communicate high growth potential to attract investors and take...

read more

Midven Director and MEIF Fund Principal, Roger Wood, starts 2020...

Having been launched in 2018, the Midlands Engine Investment Fund comprises a range of...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now

×